RII protein that they predicted would block the RII handshake, glycan binding, or both. The result: All such altered versions of the RII protein failed to bind to red blood cells, confirming the idea that drugs or vaccines that block the RII interaction, glycan binding, or both might be effective therapies for malaria.
The research reports will enable researchers to design very specific treatments for the disease. The EBA-175 protein and others related to it appear to be unique to Plasmodium, so they are excellent drug and vaccine targets, reported the researchers.
Source: Newswise
Medindia on Malaria: Further information
Malaria: Malaria is a disease caused by parasites and is spread by the mosquitoes that bite an infected person and goes on to bite a healthy person and pass on the infection. Fever, headache, vomiting and other flu like symptoms characterize the condition. The malaria attack if not treated on time can be life threatening to the patient.
For more information click here
'"/>
Page: 1 2 Related medicine news :1.
Researchers urge caution in using ear tube surgery2.
Researchers Scale to assess the Severity of Epilepsy in Kids3.
Researchers trick Alzheimers Enzyme4.
Researchers find new HIV hiding place5.
New Hair in 15 Days Could Now Be A Possibility Say Researchers 6.
Researchers developed world’s smallest toothbrus7.
Researchers discover receptor cells that can cause epilepsy
8.
15 Anti-SARS Drugs Identified By China-Europe Team of Researchers 9.
Researchers reversed the process of memory loss10.
Researchers Identify Key Gene That May Help Brain Treatment 11.
Commercialization of Biotech Discoveries, An Encouragement For Researchers